18-Feb-2020 | Zion Market Research
Zion Market Research has published a new report titled “ELISpot and FluoroSpot Assay Market by Products (Assay Kits, Analyzers and Ancillary); by Application (Research and Diagnostic); by End Users (Hospitals, Research Institutes, Biopharmaceutical Companies and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025”. According to the report, global demand for ELISpot and FluoroSpot assay market was valued at approximately USD 163.2 million in 2018, and is expected to generate revenue of around USD 451.6 million by end of 2025, growing at a CAGR of around 15.7% between 2019 and 2025.
Browse the full “ELISpot and FluoroSpot Assay Market by Products (Assay Kits, Analyzers and Ancillary); by Application (Research and Diagnostic); by End Users (Hospitals, Research Institutes, Biopharmaceutical Companies and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2025.” Report at https://www.zionmarketresearch.com/report/elispot-and-fluorospot-assay-market
ELISPOT assay is a technique for measuring T-cell responses. It is used in immunotherapy trials. T-cells secrete cytokines which are detected by the assay. It uses immuno-enzyme technology. The sample consisting of cell suspensions are placed in wells which are coated with anti-cytokine. The cytokine that is secreted is represented by blue spots that can be counted on a microscope. It is a sensitive immunologic method. There are many applications of ELISpot and FluoroSpot in diagnosis as well as research. They are used to detect antigen-specific cells and are relevant for diagnostic purposes. It is used to detect diseases such as autoimmune diseases, allergies, cancer and infections.
The ELISpot and FluoroSpot Assay market is segmented into various divisions such as application, products, end user, and region. Based on product, market is segmented into analyzers, assay kits and ancillary products. ELISA assay kits are particularly useful for detection of cytokines; they also have good reproducibility. There are many analyzers available in the market which can scan multiple well plates and address different assay formats such as those of ELISpot, viral plaque, FluoroSpot and cell counting. Assay kits segment held largest market share in 2018 as a result of technological advancements and increasing chronic disease burden.
Based on applications market is segmented into research and diagnostic applications. Diagnostic application segment is sub segmented into transplant and infectious diseases. Research applications segment is sub segmented into clinical trials, cancer research and vaccine development. Diagnostic application segment dominated the market in 2018 due to increasing prevalence of chronic diseases, infectious diseases and increasing demand for ELISpot assays for disease diagnosis. Research application segment is expected to be rapidly growing owing to increasing research activities on novel cancer diagnosis assay development and increasing cancer prevalence across the globe.
The end user segment of the ELISpot and FluoroSpot assay market is divided into hospitals, research institutes, biopharmaceutical companies and other end users. Hospitals end user segment dominated the market in 2018 whereas biopharmaceutical companies will experience highest growth over the forecast period.
Among these regions, North America is leading in this market due to the rise in number of manufacturers, improved health care infrastructure, and spread of infectious diseases and development of various new products. Increase in development of innovative products, and spread of manufacturers in their countries has led Europe to expand its global presence in the ELISpot and FluoroSpot market due to mergers and acquisitions which are increasing the presence of European markets globally. For example, companies like Mabtech provides different types of assays such as ELISA, ELISpot and many others and a variety of antibodies, immunoglobulins, cytokines and apolipoproteins. Asia Pacific has growing opportunities in the FluoroSpot and ELISpot assays market due to increase in health care funding, increase in number of manufacturers of assay kits and mergers & acquisitions. Middle East and Africa region will experience noticeable growth in the years to come. Latin America is projected to exhibit moderate growth for ELISpot and FluoroSpot market during the forecast period.
Major players in ELISpot and FluoroSpot assay market are U-Cytech Biosciences, Lophius Biosciences GmbH, Biotech Investissement Group, Autoimmun Diagnostika GmbH, Bio-Techne, Abcam, Becton, Dickinson and Company, Mabtech AB, Cellular Technology Limited (CTL) and Oxford Immunotec among others.
This report segments the ELISpot and FluoroSpot Assays Market as follows:
ELISpot and FluoroSpot Assays Market: By Products
ELISpot and FluoroSpot Assays Market: By Applications
ELISpot and FluoroSpot Assays Market: By End Users
ELISpot and FluoroSpot Assays Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651